HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yukiko K Hayashi Selected Research

Fibrosis (Cirrhosis)

10/2017Treatment with the anti-IL-6 receptor antibody attenuates muscular dystrophy via promoting skeletal muscle regeneration in dystrophin-/utrophin-deficient mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yukiko K Hayashi Research Topics

Disease

24Muscular Diseases (Myopathy)
01/2019 - 12/2004
15Muscular Dystrophies (Muscular Dystrophy)
05/2024 - 03/2003
7Distal Myopathies (Distal Muscular Dystrophy)
01/2015 - 10/2004
7Nonaka type Distal myopathy
07/2012 - 03/2004
6Miyoshi myopathy
10/2015 - 04/2003
5Cardiomyopathies (Cardiomyopathy)
11/2023 - 08/2007
5type 2B Limb-girdle muscular dystrophy
10/2015 - 12/2002
4Laminopathies
05/2024 - 11/2010
4Emery-Dreifuss Muscular Dystrophy (Scapuloperoneal Muscular Dystrophy)
11/2023 - 01/2009
4Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy)
01/2019 - 05/2003
4Muscular Atrophy (Muscle Atrophy)
10/2017 - 06/2009
4Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
10/2017 - 01/2010
4Muscle Weakness
09/2014 - 05/2007
3Dysferlinopathy
10/2015 - 07/2003
3Myositis (Idiopathic Inflammatory Myopathies)
05/2015 - 05/2007
3Atrophy
09/2014 - 09/2008
3Walker-Warburg Syndrome
11/2006 - 06/2004
2Lipodystrophy
05/2024 - 11/2010
2Progeria (Hutchinson Gilford Syndrome)
05/2024 - 11/2010
2Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy)
10/2018 - 09/2009
2Facioscapulohumeral Muscular Dystrophy
06/2016 - 04/2016
2Congenital Structural Myopathies (Centronuclear Myopathy)
02/2015 - 07/2012
2Hypertrophy
03/2014 - 09/2009
2Disease Progression
05/2013 - 06/2012
2Respiratory Insufficiency (Respiratory Failure)
01/2013 - 03/2012
2Glycogen Storage Disease Type II (Pompe's Disease)
05/2012 - 03/2012
2Mitochondrial Diseases (Mitochondrial Disease)
10/2011 - 04/2010
2Limb-girdle muscular dystrophy type 2A
04/2007 - 05/2003
2Central Core Myopathy (Central Core Disease)
06/2006 - 06/2006
2Malignant Hyperthermia
06/2006 - 06/2006
1Blister (Bulla)
05/2024
1Contracture
11/2023
1Autosomal Dominant Optic Atrophy (Dominant Optic Atrophy)
05/2022
1Drug-Related Side Effects and Adverse Reactions
08/2021
1Malnutrition (Nutritional Deficiencies)
08/2021
1Myotonic Dystrophy (Dystrophia Myotonica)
10/2017
1Fibrosis (Cirrhosis)
10/2017
1Leukoencephalopathies
10/2017
1Rhabdomyolysis
01/2017
1Glycogen Storage Disease Type IIb
12/2016
1Polymyositis
01/2016
1Osteitis Deformans (Paget's Disease of Bone)
01/2016
1Premature Aging
01/2016
1Frontotemporal Dementia (Semantic Dementia)
01/2016
1Wounds and Injuries (Trauma)
10/2015
1Hereditary Myopathy with Early Respiratory Failure
05/2015
1Hypocalcemia
02/2015

Drug/Important Bio-Agent (IBA)

19Proteins (Proteins, Gene)FDA Link
05/2024 - 05/2003
8N-acylmannosamine kinaseIBA
10/2014 - 03/2004
7DysferlinIBA
01/2020 - 07/2003
7Dystroglycans (Dystroglycan)IBA
01/2017 - 06/2004
7Uridine Diphosphate (UDP)IBA
10/2014 - 03/2004
7Racemases and Epimerases (Epimerases and Racemases)IBA
10/2014 - 03/2004
7Creatine Kinase (Creatine Phosphokinase)IBA
09/2014 - 04/2003
6N-Acetylneuraminic Acid (Sialic Acid)IBA
10/2014 - 03/2004
6EnzymesIBA
01/2012 - 03/2004
5emerinIBA
05/2024 - 07/2007
5Lamin Type A (Lamin A)IBA
05/2024 - 02/2002
5AntibodiesIBA
06/2016 - 06/2012
5Signal Recognition ParticleIBA
06/2016 - 08/2011
4LaminsIBA
01/2016 - 01/2009
4AcetylglucosamineIBA
11/2007 - 03/2004
3Caveolin 3IBA
10/2018 - 12/2004
3RNA (Ribonucleic Acid)IBA
10/2017 - 12/2002
3Glucosamine (Dona)IBA
10/2014 - 07/2012
2Interleukin-6 (Interleukin 6)IBA
10/2017 - 10/2017
2Myosin Heavy Chains (Myosin Heavy Chain)IBA
10/2017 - 01/2017
2DystrophinIBA
10/2017 - 01/2010
2UtrophinIBA
10/2017 - 01/2010
2DNA (Deoxyribonucleic Acid)IBA
04/2016 - 05/2015
2N-acetylneuraminoyllactoseIBA
10/2014 - 01/2012
2AutoantibodiesIBA
09/2014 - 08/2011
2CaveolinsIBA
05/2013 - 09/2009
2SugarsIBA
01/2012 - 05/2007
2Choline KinaseIBA
10/2011 - 06/2011
2LipidsIBA
03/2009 - 08/2008
2Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA
06/2006 - 06/2006
1Lamin Type B (Lamin B)IBA
05/2024
1MyokinesIBA
10/2017
1CytokinesIBA
10/2017
1Iron-Sulfur ProteinsIBA
10/2017
1SulfurIBA
10/2017
1IronIBA
10/2017
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
01/2017
15-HT3 Serotonin Receptors (5 HT3 Receptor)IBA
01/2017
1Serotonin ReceptorsIBA
01/2017
1Granisetron (Kytril)FDA LinkGeneric
01/2017
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2017
1RitanserinIBA
01/2017
12- (4- bromo- 2,5- dimethoxyphenyl)- N- ((2- methoxyphenyl)methyl)ethanamineIBA
01/2017
1Propranolol (Inderal)FDA LinkGeneric
01/2017
1Codon (Codons)IBA
12/2016
1Anti-Idiotypic AntibodiesIBA
06/2016
1Hepatitis C AntibodiesIBA
01/2016
1Valosin Containing ProteinIBA
01/2016
1Poly(A)-Binding Protein IIIBA
01/2016

Therapy/Procedure

6Therapeutics
10/2017 - 01/2007
1Drug Therapy (Chemotherapy)
08/2021
1Polypharmacy
08/2021
1Lasers (Laser)
10/2015